Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
Open Access
- 1 October 1994
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 269 (42) , 26449-26455
- https://doi.org/10.1016/s0021-9258(18)47215-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.Journal of Clinical Investigation, 1993
- Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptorCell, 1993
- TGF‐β regulation of epithelial cell proliferationMolecular Reproduction and Development, 1992
- Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinaseCell, 1992
- Expression cloning and characterization of the TGF-β type III receptorCell, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990
- Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: A model to study the tumoristatic action of tamoxifenJournal of Steroid Biochemistry, 1988
- Biological differences among MCF-7 human breast cancer cell lines from different laboratoriesBreast Cancer Research and Treatment, 1987
- Preparation and binding of radioactively labeled porcine transforming growth factor type βBiochemical and Biophysical Research Communications, 1986